Why do HMOs spend less? Patient selection, physician price sensitivity, and prices
Author
Abstract
Suggested Citation
DOI: 10.1016/j.jpubeco.2018.10.006
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Liran Einav & Amy Finkelstein & Stephen P. Ryan & Paul Schrimpf & Mark R. Cullen, 2013.
"Selection on Moral Hazard in Health Insurance,"
American Economic Review, American Economic Association, vol. 103(1), pages 178-219, February.
- Liran Einav & Amy Finkelstein & Stephen Ryan & Paul Schrimpf & Mark Cullen, 2011. "Selection on Moral Hazard in Health Insurance," Discussion Papers 10-027, Stanford Institute for Economic Policy Research.
- Liran Einav & Amy Finkelstein & Stephen P. Ryan & Paul Schrimpf & Mark R. Cullen, 2011. "Selection on Moral Hazard in Health Insurance," NBER Working Papers 16969, National Bureau of Economic Research, Inc.
- Zack Cooper & Stuart V Craig & Martin Gaynor & John Van Reenen, 2019.
"The Price Ain’t Right? Hospital Prices and Health Spending on the Privately Insured,"
The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 134(1), pages 51-107.
- Cooper, Zack & Craig, Stuart & Gaynor, Martin & Van Reenen, John, 2015. "The price ain’t right? hospital prices and healthspending on the privately insured," LSE Research Online Documents on Economics 66059, London School of Economics and Political Science, LSE Library.
- Zack Cooper & Stuart V. Craig & Martin Gaynor & John Van Reenen, 2015. "The Price Ain’t Right? Hospital Prices and Health Spending on the Privately Insured," NBER Working Papers 21815, National Bureau of Economic Research, Inc.
- Zack Cooper & Stuart Craig & Martin Gaynor & John Van Reenen, 2015. "The Price Ain't Right? Hospital Prices and Health Spending on the Privately Insured," CEP Discussion Papers dp1395, Centre for Economic Performance, LSE.
- Cooper, Zack & Craig, Stuart V & Gaynor, Martin & Van Reenen, John, 2019. "The price ain’t right? Hospital prices and health spending on the privately insured," LSE Research Online Documents on Economics 101435, London School of Economics and Political Science, LSE Library.
- Martin Gaynor & James B. Rebitzer & Lowell J. Taylor, 2004. "Physician Incentives in Health Maintenance Organizations," Journal of Political Economy, University of Chicago Press, vol. 112(4), pages 915-931, August.
- Abe Dunn, 2012.
"Drug Innovations and Welfare Measures Computed from Market Demand: The Case of Anti-cholesterol Drugs,"
American Economic Journal: Applied Economics, American Economic Association, vol. 4(3), pages 167-189, July.
- Abe Dunn, 2010. "Drug Innovations and Welfare Measures Computed from Market Demand: The Case of Anti-Cholesterol Drugs," BEA Working Papers 0057, Bureau of Economic Analysis.
- Altman, Daniel & Cutler, David & Zeckhauser, Richard, 2003.
"Enrollee mix, treatment intensity, and cost in competing indemnity and HMO plans,"
Journal of Health Economics, Elsevier, vol. 22(1), pages 23-45, January.
- Daniel Altman & David M. Cutler & Richard Zeckhauser, 2000. "Enrollee Mix, Treatment Intensity, and Cost in Competing Indemnity and HMO Plans," NBER Working Papers 7832, National Bureau of Economic Research, Inc.
- Altman, Daniel & Cutler, David & Zeckhauser, Richard J., 2003. "Enrollee Mix, Treatment Intensity, and Cost in Competing Indemnity and HMO Plans," Scholarly Articles 2664300, Harvard University Department of Economics.
- Anna Aizer & Janet Currie & Enrico Moretti, 2007. "Does Managed Care Hurt Health? Evidence from Medicaid Mothers," The Review of Economics and Statistics, MIT Press, vol. 89(3), pages 385-399, August.
- Judith K. Hellerstein, 1998. "The Importance of the Physician in the Generic Versus Trade-Name Prescription Decision," RAND Journal of Economics, The RAND Corporation, vol. 29(1), pages 108-136, Spring.
- Lee Branstetter & Chirantan Chatterjee & Matthew J. Higgins, 2016.
"Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry,"
RAND Journal of Economics, RAND Corporation, vol. 47(4), pages 857-890, November.
- Lee G. Branstetter & Chirantan Chatterjee & Matthew Higgins, 2011. "Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry," NBER Working Papers 17188, National Bureau of Economic Research, Inc.
- Farasat A. S. Bokhari & Gary M. Fournier, 2013.
"Entry in the ADHD drugs market: Welfare impact of generics and me-too's,"
Journal of Industrial Economics, Wiley Blackwell, vol. 61(2), pages 339-392, June.
- Farasat A.S. Bokhari & Gary M. Fournier, 2009. "Entry in the ADHD drugs market: Welfare impact of generics and me-toos," Working Papers wp2009_05_01, Department of Economics, Florida State University.
- Kate Ho & Ariel Pakes, 2014.
"Hospital Choices, Hospital Prices, and Financial Incentives to Physicians,"
American Economic Review, American Economic Association, vol. 104(12), pages 3841-3884, December.
- Kate Ho & Ariel Pakes, 2013. "Hospital Choices, Hospital Prices and Financial Incentives to Physicians," NBER Working Papers 19333, National Bureau of Economic Research, Inc.
- Marsha Gold & Gretchen Jacobson & Anthony Damico & Tricia Neuman, "undated". "Medicare Advantage Enrollment Market Update," Mathematica Policy Research Reports e83f2db159ff40ea89dd61897, Mathematica Policy Research.
- Gretchen Jacobson & Anthony Damico & Tricia Neuman & Marsha Gold, "undated". "Medicare Advantage 2017 Spotlight: Enrollment Market Update," Mathematica Policy Research Reports 26591c8eba9c4b719df846205, Mathematica Policy Research.
- Katherine Baicker & Sendhil Mullainathan & Joshua Schwartzstein, 2015.
"Behavioral Hazard in Health Insurance,"
The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 130(4), pages 1623-1667.
- Katherine Baicker & Sendhil Mullainathan & Joshua Schwartzstein, 2012. "Behavioral Hazard in Health Insurance," NBER Working Papers 18468, National Bureau of Economic Research, Inc.
- Paul Ellickson & Scott Stern & Manuel Trajtenberg, 2001.
"Patient Welfare and Patient Compliance -- An Empirical Framework for Measuring the Benefits from Pharmaceutical Innovation,"
NBER Chapters, in: Medical Care Output and Productivity, pages 539-564,
National Bureau of Economic Research, Inc.
- Paul Ellickson & Scott Stern & Manuel Trajtenberg, 1999. "Patient Welfare and Patient Compliance: An Empirical Framework for Measuring the Benefits from Pharmaceutical Innovation," NBER Working Papers 6890, National Bureau of Economic Research, Inc.
- Limbrock Frank, 2011. "Pecuniary and Non-Pecuniary Incentives in Prescription Pharmaceuticals: The Case of Statins," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 11(2), pages 1-30, January.
- McClellan, Mark & Cutler, David & Newhous, Joseph P., 2000. "How Does Managed Care Do It?," Scholarly Articles 2643884, Harvard University Department of Economics.
- Arcidiacono, Peter & Ellickson, Paul B. & Landry, Peter & Ridley, David B., 2013.
"Pharmaceutical followers,"
International Journal of Industrial Organization, Elsevier, vol. 31(5), pages 538-553.
- Peter Arcidiacono & Paul B. Ellickson & Peter Landry & David B. Ridley, 2013. "Pharmaceutical Followers," NBER Working Papers 19522, National Bureau of Economic Research, Inc.
- Stern, S. & Trajtenberg, M., 1998.
"Empirical Implications of Physician Authority in Pharmaceutical Decisionmaking,"
Papers
24-98, Tel Aviv.
- Scott Stern & Manuel Trajtenberg, 1998. "Empirical Implications of Physician Authority in Pharmaceutical Decisionmaking," NBER Working Papers 6851, National Bureau of Economic Research, Inc.
- Panle Jia & Pinelopi K. Goldberg & Shubham Chaudhuri, 2006.
"Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India,"
American Economic Review, American Economic Association, vol. 96(5), pages 1477-1514, December.
- Shubham Chaudhuri & Pinelopi K. Goldberg & Panle Jia, 2003. "Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India," NBER Working Papers 10159, National Bureau of Economic Research, Inc.
- Shubham Chaudhuri, 2006. "Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India," Working Papers id:772, eSocialSciences.
- Amitabh Chandra & Jonathan Gruber & Robin McKnight, 2010.
"Patient Cost-Sharing and Hospitalization Offsets in the Elderly,"
American Economic Review, American Economic Association, vol. 100(1), pages 193-213, March.
- Chandra, Amitabh & Gruber, Jonathan & McKnight, Robin, 2009. "Patient Cost-Sharing and Hospitalization Offsets in the Elderly," Scholarly Articles 8058412, Harvard Kennedy School of Government.
- repec:bla:jindec:v:48:y:2000:i:3:p:349-69 is not listed on IDEAS
- Andrew T. Ching & Masakazu Ishihara, 2012. "Measuring the Informative and Persuasive Roles of Detailing on Prescribing Decisions," Management Science, INFORMS, vol. 58(7), pages 1374-1387, July.
- Mark Duggan & Tamara Hayford, 2013.
"Has the Shift to Managed Care Reduced Medicaid Expenditures? Evidence from State and Local‐Level Mandates,"
Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 32(3), pages 505-535, June.
- Mark Duggan & Tamara Hayford, 2011. "Has the Shift to Managed Care Reduced Medicaid Expenditures? Evidence from State and Local-Level Mandates," NBER Working Papers 17236, National Bureau of Economic Research, Inc.
- Duggan, Mark, 2004.
"Does contracting out increase the efficiency of government programs? Evidence from Medicaid HMOs,"
Journal of Public Economics, Elsevier, vol. 88(12), pages 2549-2572, December.
- Mark Duggan, 2002. "Does Contracting Out Increase the Efficiency of Government Programs? Evidence from Medicaid HMOs," NBER Working Papers 9091, National Bureau of Economic Research, Inc.
- David M. Cutler & Mark McClellan & Joseph P. Newhouse, 2000. "How Does Managed Care Do It?," RAND Journal of Economics, The RAND Corporation, vol. 31(3), pages 526-548, Autumn.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Ding, Yu & Liu, Chenyuan, 2021. "Alternative payment models and physician treatment decisions: Evidence from lower back pain," Journal of Health Economics, Elsevier, vol. 80(C).
- Yin, Nina, 2023. "Pharmaceuticals, incremental innovation and market exclusivity," International Journal of Industrial Organization, Elsevier, vol. 87(C).
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Martin Gaynor & Kate Ho & Robert J. Town, 2015.
"The Industrial Organization of Health-Care Markets,"
Journal of Economic Literature, American Economic Association, vol. 53(2), pages 235-284, June.
- Martin Gaynor & Kate Ho & Robert Town, 2014. "The Industrial Organization of Health Care Markets," NBER Working Papers 19800, National Bureau of Economic Research, Inc.
- Benjamin R. Handel & Kate Ho, 2021. "Industrial Organization of Health Care Markets," NBER Working Papers 29137, National Bureau of Economic Research, Inc.
- Ding, Yu & Liu, Chenyuan, 2021. "Alternative payment models and physician treatment decisions: Evidence from lower back pain," Journal of Health Economics, Elsevier, vol. 80(C).
- Branstetter, Lee & Chatterjee, Chirantan & Higgins, Matthew J., 2022.
"Generic competition and the incentives for early-stage pharmaceutical innovation,"
Research Policy, Elsevier, vol. 51(10).
- Lee Branstetter & Chirantan Chatterjee & Matthew J. Higgins, 2014. "Generic Competition and the Incentives for Early-Stage Pharmaceutical Innovation," NBER Working Papers 20532, National Bureau of Economic Research, Inc.
- David Dranove & Christopher Ody & Amanda Starc, 2021.
"A Dose of Managed Care: Controlling Drug Spending in Medicaid,"
American Economic Journal: Applied Economics, American Economic Association, vol. 13(1), pages 170-197, January.
- David Dranove & Christopher Ody & Amanda Starc, 2017. "A Dose of Managed Care: Controlling Drug Spending in Medicaid," NBER Working Papers 23956, National Bureau of Economic Research, Inc.
- Tomaso Duso & Annika Herr & Moritz Suppliet, 2014.
"The Welfare Impact Of Parallel Imports: A Structural Approach Applied To The German Market For Oral Anti‐Diabetics,"
Health Economics, John Wiley & Sons, Ltd., vol. 23(9), pages 1036-1057, September.
- Duso, T. & Herr, A. & Suppliet, M, 2014. "The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral Anti-diabetics," Health, Econometrics and Data Group (HEDG) Working Papers 14/09, HEDG, c/o Department of Economics, University of York.
- Tomaso Duso & Annika Herr & Moritz Suppliet, 2014. "The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral Anti-Diabetics," Discussion Papers of DIW Berlin 1373, DIW Berlin, German Institute for Economic Research.
- Duso, Tomaso & Herr, Annika & Suppliet, Moritz, 2014. "The welfare impact of parallel imports: A structural approach applied to the German market for oral anti-diabetics," DICE Discussion Papers 137, Heinrich Heine University Düsseldorf, Düsseldorf Institute for Competition Economics (DICE).
- Suppliet, Moritz & Duso, Tomaso & Herr, Annika, 2014. "The welfare impact of parallel imports: A structural approach applied to the German market for oral antidiabetics," VfS Annual Conference 2014 (Hamburg): Evidence-based Economic Policy 100298, Verein für Socialpolitik / German Economic Association.
- Marton, James & Yelowitz, Aaron & Talbert, Jeffery C., 2014.
"A tale of two cities? The heterogeneous impact of medicaid managed care,"
Journal of Health Economics, Elsevier, vol. 36(C), pages 47-68.
- Marton, James & Yelowitz, Aaron & Talbert, Jeffrey, 2014. "A Tale of Two Cities? The Heterogeneous Impact of Medicaid Managed Care," MPRA Paper 54105, University Library of Munich, Germany.
- Lee, Ajin, 2020. "How do hospitals respond to managed care? Evidence from at-risk newborns," Journal of Public Economics, Elsevier, vol. 184(C).
- Elizabeth L. Munnich & Michael R. Richards, 2020. "Treatment flows after outsourcing public insurance provision: Evidence from Florida Medicaid," Health Economics, John Wiley & Sons, Ltd., vol. 29(11), pages 1343-1363, November.
- Lindsey Woodworth, 2016. "A Leak in the Lifeboat: The effect of Medicaid managed care on the vitality of safety-net hospitals," Journal of Regulatory Economics, Springer, vol. 50(3), pages 251-270, December.
- Victoria Perez, 2018. "Effect of privatized managed care on public insurance spending and generosity: Evidence from Medicaid," Health Economics, John Wiley & Sons, Ltd., vol. 27(3), pages 557-575, March.
- Kate Ho & Ariel Pakes, 2014.
"Hospital Choices, Hospital Prices, and Financial Incentives to Physicians,"
American Economic Review, American Economic Association, vol. 104(12), pages 3841-3884, December.
- Kate Ho & Ariel Pakes, 2013. "Hospital Choices, Hospital Prices and Financial Incentives to Physicians," NBER Working Papers 19333, National Bureau of Economic Research, Inc.
- Atwood, Alicia & Lo Sasso, Anthony T., 2016. "The effect of narrow provider networks on health care use," Journal of Health Economics, Elsevier, vol. 50(C), pages 86-98.
- Callejas, Jerónimo & Mohapatra, Debi Prasad, 2021. "Welfare effects of public procurement of medicines: Evidence from Ecuador," International Journal of Industrial Organization, Elsevier, vol. 75(C).
- Anderson, David M. & Hoagland, Alex & Zhu, Ed, 2024.
"Medical bill shock and imperfect moral hazard,"
Journal of Public Economics, Elsevier, vol. 236(C).
- Alex Hoagland & David M. Anderson & Ed Zhu, 2022. "Medical Bill Shock and Imperfect Moral Hazard," Papers 2211.01116, arXiv.org, revised Mar 2024.
- Abe Dunn & Adam Hale Shapiro, 2018.
"Physician Competition and the Provision of Care: Evidence from Heart Attacks,"
American Journal of Health Economics, MIT Press, vol. 4(2), pages 226-261, Spring.
- Abe Dunn & Adam Hale Shapiro, 2018. "Physician Competition and the Provision of Care: Evidence from Heart Attacks," American Journal of Health Economics, University of Chicago Press, vol. 4(2), pages 226-261, Spring.
- Abe Dunn & Adam Hale Shapiro, 2015. "Physician competition and the provision of care: evidence from heart attacks," Working Paper Series 2015-7, Federal Reserve Bank of San Francisco.
- Michael Geruso & Timothy J. Layton & Jacob Wallace, 2023.
"What Difference Does a Health Plan Make? Evidence from Random Plan Assignment in Medicaid,"
American Economic Journal: Applied Economics, American Economic Association, vol. 15(3), pages 341-379, July.
- Michael Geruso & Timothy J. Layton & Jacob Wallace, 2020. "What Difference Does a Health Plan Make? Evidence from Random Plan Assignment in Medicaid," NBER Working Papers 27762, National Bureau of Economic Research, Inc.
- Marianne P. Bitler & Madeline Zavodny, 2014. "Medicaid: A Review of the Literature," NBER Working Papers 20169, National Bureau of Economic Research, Inc.
- Liran Einav & Amy Finkelstein & Maria Polyakova, 2018.
"Private Provision of Social Insurance: Drug-Specific Price Elasticities and Cost Sharing in Medicare Part D,"
American Economic Journal: Economic Policy, American Economic Association, vol. 10(3), pages 122-153, August.
- Liran Einav & Amy Finkelstein & Maria Polyakova, 2016. "Private Provision of Social Insurance: Drug-specific Price Elasticities and Cost Sharing in Medicare Part D," NBER Working Papers 22277, National Bureau of Economic Research, Inc.
- Müller, Tobias & Schmid, Christian & Gerfin, Michael, 2023.
"Rents for Pills: Financial incentives and physician behavior,"
Journal of Health Economics, Elsevier, vol. 87(C).
- Gerfin, Michael & Müller, Tobias & Schmid, Christian, 2022. "Rents for Pills: Financial Incentives and Physician Behavior," VfS Annual Conference 2022 (Basel): Big Data in Economics 264037, Verein für Socialpolitik / German Economic Association.
- Craig, Stuart V. & Ericson, Keith Marzilli & Starc, Amanda, 2021. "How important is price variation between health insurers?," Journal of Health Economics, Elsevier, vol. 77(C).
More about this item
Keywords
Health insurance; HMOs spending; Prescription drug demand;All these keywords.
JEL classification:
- G22 - Financial Economics - - Financial Institutions and Services - - - Insurance; Insurance Companies; Actuarial Studies
- I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets
- I13 - Health, Education, and Welfare - - Health - - - Health Insurance, Public and Private
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:pubeco:v:168:y:2018:i:c:p:146-161. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/locate/inca/505578 .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.